Naoto T. Ueno: Breakthrough Advances in K-RAS Inhibitor Development

Naoto T Ueno, Director of the University of Hawaii Cancer Center, shared a post on X:

“It’s exciting to learn what’s most reviewed. For me, the development of K-RAS inhibitors is truly a breakthrough.